{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:08:10Z","timestamp":1791122890977,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010902","name":"Vanda Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010902","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","cghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cgh.2024.01.005","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T04:59:12Z","timestamp":1705467552000},"page":"2506-2516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The Efficacy of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Phase 3 Randomized Placebo-Controlled Clinical Trial"],"prefix":"10.1016","volume":"22","author":[{"given":"Jesse L.","family":"Carlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Polymeropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lembo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleigh","family":"Kupersmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darby","family":"Madonick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Moszczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Smieszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunther","family":"Birznieks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihael H.","family":"Polymeropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.01.005_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-018-0038-z","article-title":"Gastroparesis","volume":"4","author":"Camilleri","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.cgh.2024.01.005_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.gastro.2021.10.028","article-title":"Gastroparesis","volume":"162","author":"Camilleri","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.005_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.gastro.2021.09.064","article-title":"Epidemiology, etiology, and treatment of gastroparesis: real-world evidence from a large US National Claims Database","volume":"162","author":"Ye","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.005_bib4","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2004.09.055","article-title":"American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis","volume":"127","author":"Parkman","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.005_bib5","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.cgh.2011.08.013","article-title":"Similarities and differences between diabetic and idiopathic gastroparesis","volume":"9","author":"Parkman","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.01.005_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5056\/jnm.2012.18.1.34","article-title":"Prevalence of hidden gastroparesis in the community: the gastroparesis \u201ciceberg.\u201d","volume":"18","author":"Rey","year":"2012","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2024.01.005_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2012.373","article-title":"Clinical guideline: management of gastroparesis","volume":"108","author":"Camilleri","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.005_bib8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.14309\/ajg.0000000000001874","article-title":"ACG clinical guideline: gastroparesis","volume":"117","author":"Camilleri","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.005_bib9","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/nmo.12893","article-title":"Nausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesis","volume":"28","author":"Parkman","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2024.01.005_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1053\/j.gastro.2005.10.019","article-title":"Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia","volume":"130","author":"Karamanolis","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.005_bib11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1572-0241.2003.07389.x","article-title":"Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia","volume":"98","author":"Sarnelli","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.005_bib12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/gutjnl-2018-316405","article-title":"Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysis","volume":"68","author":"Vijayvargiya","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.01.005_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0143-4179(98)90015-4","article-title":"The tachykinin NK1 receptor. Part II: distribution and pathophysiological roles","volume":"32","author":"Quartara","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1016\/j.cgh.2024.01.005_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0197-0186(85)90106-8","article-title":"Neuroactive substances in the dorsal vagal complex of the medulla oblongata: nucleus of the tractus solitarius, area postrema, and dorsal motor nucleus of the vagus","volume":"7","author":"Leslie","year":"1985","journal-title":"Neurochem Int"},{"key":"10.1016\/j.cgh.2024.01.005_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1515\/bmc-2013-0001","article-title":"Neurokinin receptors in the gastrointestinal muscle wall: cell distribution and possible roles","volume":"4","author":"Vannucchi","year":"2013","journal-title":"Biomol Concepts"},{"key":"10.1016\/j.cgh.2024.01.005_bib16","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1517\/17425255.2010.513970","article-title":"Pharmacokinetic evaluation of fosaprepitant dimeglumine","volume":"6","author":"Colon-Gonzalez","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.cgh.2024.01.005_bib17","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s40265-021-01558-2","article-title":"Netupitant\/palonosetron: a review in chemotherapy-induced nausea and vomiting","volume":"81","author":"Shirley","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.cgh.2024.01.005_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archsurg.2010.327","article-title":"Casopitant and ondansetron for postoperative nausea and vomiting prevention in women at high risk for emesis: a phase 3 study","volume":"146","author":"Altorjay","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/j.cgh.2024.01.005_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/VMRR.S126469","article-title":"Spotlight on the perioperative use of maropitant citrate","volume":"8","author":"Hay Kraus","year":"2017","journal-title":"Vet Med Res Reports"},{"key":"10.1016\/j.cgh.2024.01.005_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.gastro.2017.08.033","article-title":"Aprepitant has mixed effects on nausea and reduces other symptoms in patients with gastroparesis and related disorders","volume":"154","author":"Pasricha","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.005_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrendo.2009.50","article-title":"A\u00a0case of severe, refractory diabetic gastroparesis managed by prolonged use of aprepitant","volume":"5","author":"Chong","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.cgh.2024.01.005_bib22","first-page":"3218","article-title":"Successful management of refractory diabetic gastroparesis with long-term aprepitant treatment","volume":"12","author":"Fountoulakis","year":"2017","journal-title":"ARPN J Eng Appl Sci"},{"key":"10.1016\/j.cgh.2024.01.005_bib23","doi-asserted-by":"crossref","first-page":"G505","DOI":"10.1152\/ajpgi.00197.2017","article-title":"Effects of nk1 receptors on gastric motor functions and satiation in healthy humans: Results from a controlled trial with the nk1 antagonist aprepitant","volume":"313","author":"Jacob","year":"2017","journal-title":"Am J Physiol - Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2024.01.005_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.gastro.2020.07.029","article-title":"Efficacy and safety of tradipitant in patients with diabetic and idiopathic gastroparesis in a randomized, placebo-controlled trial","volume":"160","author":"Carlin","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.005_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.563373","article-title":"Tradipitant in the treatment of motion sickness: a randomized, double-blind, placebo-controlled study","volume":"11","author":"Polymeropoulos","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.cgh.2024.01.005_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s41687-018-0081-2","article-title":"The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis","volume":"2","author":"Revicki","year":"2018","journal-title":"J\u00a0Patient-Reported Outcomes"},{"key":"10.1016\/j.cgh.2024.01.005_bib27","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1365-2036.2009.04078.x","article-title":"Development and content validity of a gastroparesis cardinal symptom index daily diary","volume":"30","author":"Revicki","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.01.005_bib28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2982.2012.01879.x","article-title":"Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD)","volume":"24","author":"Revicki","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2024.01.005_bib29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1464-5491.2008.02428.x","article-title":"Upper abdominal symptoms in patients with type 1 diabetes: Unrelated to impairment in gastric emptying caused by autonomic neuropathy","volume":"25","author":"Punkkinen","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.cgh.2024.01.005_bib30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2982.2007.01054.x","article-title":"Association between changes in symptoms and gastric emptying in gastroparetic patients treated with gastric electrical stimulation","volume":"20","author":"Lin","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2024.01.005_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-3485.83221","article-title":"Intention-to-treat concept: A review","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.cgh.2024.01.005_bib32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/wps.20246","article-title":"Time to abandon placebo control in pivotal phase III trials?","volume":"14","author":"Geddes","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.cgh.2024.01.005_bib33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1176\/appi.ajp.2012.12040474","article-title":"A\u00a0model of placebo response in antidepressant clinical trials","volume":"170","author":"Rutherford","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.cgh.2024.01.005_bib34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrgastro.2015.117","article-title":"Placebo effects and their determinants in gastrointestinal disorders","volume":"12","author":"Elsenbruch","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.01.005_bib35","doi-asserted-by":"crossref","first-page":"e14474","DOI":"10.1111\/nmo.14474","article-title":"Placebo response in pharmacological trials in patients with functional dyspepsia\u2014a systematic review and meta-analysis","volume":"35","author":"Bosman","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2024.01.005_bib36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/j.gastro.2022.12.014","article-title":"Efficacy and safety of drugs for gastroparesis: systematic review and network meta-analysis","volume":"164","author":"Ingrosso","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.005_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3389\/fpsyt.2020.00797","article-title":"Placebo responses and placebo effects in functional gastrointestinal disorders","volume":"11","author":"Enck","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.cgh.2024.01.005_bib38","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cgh.2022.09.033","article-title":"Response and adverse event rates with placebo in gastroparesis: a systematic review and meta-analysis","volume":"21","author":"Wise","year":"2023","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T18:49:51Z","timestamp":1732301391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1542356524000508"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.01.005","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Efficacy of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Phase 3 Randomized Placebo-Controlled Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}